Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
KJERtLsdedpBtBXC
